These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14697993)

  • 1. Pravastatin decreases cold ischemia--but not alloantigen-dependent transplant arteriosclerosis.
    Domínguez J; Schultz M
    Transplant Proc; 2003 Dec; 35(8):3121-4. PubMed ID: 14697993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated arteriosclerosis in aortic grafts: a role for activated complement and IgM antibody in early lesion development.
    Geerling RA; Ansari AA; LaFond-Walker AM; Baumgartner WA; Herskowitz A
    Transplant Proc; 1998 Jun; 30(4):1017-9. PubMed ID: 9636411
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.
    Cole OJ; Shehata M; Rigg KM
    Transplant Proc; 1998 Aug; 30(5):2200-3. PubMed ID: 9723440
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of alloantigen-independent factors in transplant arteriosclerosis.
    Kouwenhoven EA; Marquet RL; Bonthuis F; IJzermans JN; de Bruin RW
    Transplant Proc; 1997 May; 29(3):1721-2. PubMed ID: 9142246
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged cold preservation promotes the recipient's cell participating in neointima formation but delays the later graft arteriosclerosis in rat model.
    Xiong W; Gao CJ; Lu XF; Cheng JQ; Li YP
    Transplant Proc; 2005; 37(1):312-5. PubMed ID: 15808628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by topical exposure to IGF-I.
    Motomura N; Lou H; Hong M; Tsutsumi Y; Mayumi T; Foegh ML
    Transplant Proc; 1997; 29(1-2):1118-20. PubMed ID: 9123226
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I.
    Motomura N; Lou H; Maurice P; Foegh ML
    Transplantation; 1997 Apr; 63(7):932-6. PubMed ID: 9112342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
    Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-induced transplant arteriosclerosis in the rat.
    Wanders A; Akyürek ML; Waltenberger J; Ren ZP; Stafberg C; Funa K; Larsson E; Fellström B
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):145-55. PubMed ID: 7749811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transplant arteriosclerosis in rat aortic grafts by low molecular weight heparin derivatives.
    Akyürek LM; Funa K; Wanders A; Larsson E; Fellström BC
    Transplantation; 1995 Jun; 59(11):1517-24. PubMed ID: 7778166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of intimal hyperplasia employing the cavitary two-layer method in allogeneic rat heart transplantation.
    Fujino Y; Kamoda Y; Tanioka Y; Sakai T; Kuroda Y
    J Surg Res; 2012 Jul; 176(1):275-80. PubMed ID: 21840018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiopeptin on transplant arteriosclerosis in the rat.
    Akyürek ML; Wanders A; Aurivillius M; Larsson E; Funa K; Fellström BC
    Transpl Int; 1995; 8(2):103-10. PubMed ID: 7766291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of recombinant human superoxide dismutase on cold ischemia-induced arteriosclerosis in syngeneic rat aortic transplants.
    Myllärniemi M; Räisänen-Sokolowski A; Vuoristo P; Kallio E; Land W; Häyry P
    Transplantation; 1996 Apr; 61(7):1018-22. PubMed ID: 8623179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of vascular allografts to insulin-like growth factor-I (IGF-I) increases vascular expression of IGF-I ligand and receptor protein and accelerates arteriosclerosis in rats.
    Motomura N; Lou H; Orskov H; Ramwell PW; Foegh ML
    Transplantation; 1998 Apr; 65(8):1024-30. PubMed ID: 9583860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease therapy alleviates allograft arteriosclerosis in rats.
    Gaciong Z; Paczek L; Bojakowski K; Socha K; Wiśniewski M; Lietz K; Lao M; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3439-40. PubMed ID: 8962341
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model.
    Gaciong Z; Paczek L; Bojakowski K; Socha K; Wisniewski M; Heidland A
    Nephrol Dial Transplant; 1996 Jun; 11(6):987-9. PubMed ID: 8671957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and transplant arteriosclerosis in absence of alloreactivity and immunosuppressive drugs in a rat aortic model: recipient age's contribution.
    Calfa M; Aïtouche A; Vazquez-Padron RI; Gay-Rabinstein C; Lasko D; Badell J; Farji A; El-Haddad A; Liotta C; Louis LB; Simmonds A; Pestana IA; Pang M; Li S; Pham SM
    Transplantation; 2005 Jun; 79(12):1683-90. PubMed ID: 15973169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.